ゾレドロン酸とデノスマブは,2型糖尿病患者の骨折発生率と死亡率に類似している:集団ベースのコホート研究
PubMedで要約を見る
まとめ
この要約は機械生成です。ゾレドロニン酸とデノスマブは,2型糖尿病と骨粗鬆症の患者の主要な骨折を予防し,死亡率を低下させるのに類似した有効性を示しています. この2つの治療法では 比較可能な結果が得られます
科学分野
- 内分泌学
- 高齢者医療
- 薬理学について
背景
- 2型糖尿病と骨粗鬆症は共同疾患であり,骨折のリスクと死亡率を増加させます.
- ビスホスフォネートとモノクローン抗体は,骨粗鬆症の主要な治療法ですが,糖尿病患者の比較効果は不明です.
研究 の 目的
- 主要な骨粗鬆症の骨折と死亡率の予防におけるゾレドロン酸とデノスマブの有効性を比較する.
- 2型糖尿病と骨粗鬆症の両方の患者でこれらのアウトカムを評価する.
主な方法
- 糖尿病と骨粗鬆症のレジスタリを使用した遡及的なコホート研究.
- ゾレドロン酸またはデノスマブを投与した患者を比較するために,傾向スコアのマッチングが使用されました.
- カプラン・マイヤー曲線と多変量コックスモデルは 骨折と死亡リスクを評価した.
主要な成果
- 415組の患者を分析した.
- 5年間の累積的な骨折 (38% 対 31%) と死亡 (36% 対 41%) の発生率は,グループ間で類似した.
- 全体的な骨折リスク (1. 17) と死亡リスク (1. 12) の危険比率は有意な違いを示さなかった.
結論
- ゾレドロニン酸とデノスマブは,骨粗鬆症の骨折の管理に類似した有効性を示しています.
- 2型糖尿病と骨粗鬆症の患者では,両薬の死亡率が類似しているようです.
- これらの発見は,この患者群における骨折の予防のためのいずれかの薬剤の使用を支持する.
関連する概念動画
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormonal Control of Bone Remodeling
Parathyroid hormone (PTH) maintains homeostatic control of blood calcium levels by regulating bone resorption. PTH is...
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

